A board to discuss the soon-to-be released drug Campath as a treatment for Multiple Sclerosis
The FDA have sent Genzyme/Sanofi a refuse to file letter. They're not asking for more trials, just for more info at the moment, but it will put back approval in the US by another 6 months or so. The EMA in Europe have accepted the application.
- Posts: 9
- Joined: Tue Jan 12, 2010 4:00 pm
Return to Campath (Lemtrada, Alemtuzumab)
Who is online
Users browsing this forum: No registered users